Most notably, a humanized monoclonal antibody against CX3CL1 has also been found to be safe and well-tolerated in the clinic when used in Rheumatoid Arthritis and Crohn’s Disease patients (Imai and Yasuda, 2016). Here, CX3CL1 is linked to rheumatoid arthritis.